Biohaven's Phase 2 Obesity Study with Taldefgrobep Alfa, a Novel Myostatin-Activin Pathway Inhibitor, Completes Enrollment Biohaven (NYSE: BHVN) completed enrollment in a Phase 2 randomized, double-blind, placebo-controlled study of taldefgrobep alfa in adults with overweight and obesity, targeting ~150 randomized participants across 20 US sites. Topline data are expected in 2H 2026.The 24-week double-blind period evaluates percent change in total body weight (primary) and body fat and lean mass (secondary); an additional 24-week open-label extension follows.

#BHVN Biohaven's Phase 2 Obesity Study with Taldefgrobep Alfa, a Novel Myostatin-Activin Pathway Inhibitor, Completes Enrollment

www.stocktitan.net/news/BHVN/biohaven-s-pha...

Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results Biohaven (NYSE: BHVN) reported 4Q and full‑year 2025 results and highlighted clinical and corporate progress. Key clinical highlights include BHV-1300 IgG reductions up to 87%, BHV-1400 Gd‑IgA1 reductions up to 81%, and opakalim OLE seizure reductions ≥50% in most participants. Cash and equivalents totaled $322.0M at Dec 31, 2025, with an additional $178.9M raised via 17.2M shares sold in 2026. The company announced a restructuring to target a ~60% reduction in annual direct R&D spend while accelerating pivotal trials for degraders and opakalim in 2026.

#BHVN Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results

www.stocktitan.net/news/BHVN/biohaven-repor...

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#IREN, #VKTX, #BHVN, #HUT, #SOFI

#OptionFlow #OptionsTrading #Trading

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#BHVN, #SBSW, #CLSK, #GEV, #META

#OptionFlow #OptionsTrading #Trading

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! AM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

AM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #BMNR 61% OTM
2. #PLTR 45% OTM
3. #BHVN 34% OTM
4. #ASTS 32% OTM
5. #MSTR 29% OTM

#OptionFlow #OptionsTrading #Trading

Biohaven Provides Update From Phase 2 Proof-of-Concept Study with BHV-7000 in Major Depressive Disorder Biohaven (NYSE: BHVN) reported results from a Phase 2 proof-of-concept study of BHV-7000 in major depressive disorder (MDD) on Dec. 24, 2025. The study did not meet its primary endpoint (change in MADRS over six weeks versus placebo). Trends favoring BHV-7000 were observed in some clinically relevant subgroups, including participants with more severe depression at screening and baseline. Overall safety was acceptable: adverse events were mostly mild or moderate and largely resolved, with headache (10.7% vs 9.9%) and nausea (4.2% vs 5.6%) as the only events >5% in any arm. Additional analyses are ongoing and Biohaven will present updates at the J.P. Morgan Healthcare Conference in Jan 2026. The company does not plan additional psychiatric trials in 2026 to prioritize immunology, obesity, and epilepsy programs.

#BHVN Biohaven Provides Update From Phase 2 Proof-of-Concept Study with BHV-7000 in Major Depressive Disorder

www.stocktitan.net/news/BHVN/biohaven-provi...

Biohaven Announces Pricing of $175 Million Public Offering of Common Shares NEW HAVEN, Conn., Nov. 12, 2025/ PRNewswire/-- Biohaven Ltd., a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today announced the pricing of its underwritten public offering of 23,333,334 of its common shares at a price to...

#BHVN Biohaven Announces Pricing of $175 Million Public Offering of Common Shares

www.stocktitan.net/news/BHVN/biohaven-annou...

Biohaven Reports Financial Results for Q3 2025 and Strategic Developments in Drug Pipeline Biohaven Ltd. shared its financial results for Q3 2025, highlighting advancements in clinical programs and a focus on optimizing resources for innovative therapies.

Biohaven Reports Financial Results for Q3 2025 and Strategic Developments in Drug Pipeline #USA #Biohaven #New_Haven #BHVN #Opakalim

Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments NEW HAVEN, Conn., Nov. 10, 2025/ PRNewswire/-- Biohaven Ltd., a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today reported financial results for the third quarter ended September 30, 2025, and provided a review of...

#BHVN Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments

www.stocktitan.net/news/BHVN/biohaven-repor...

Most Searched, Wednesday November 5, 2025 – Crystal Equity Research

Most searched small-cap stocks, Wed Nov 5th - #CMBM #TE #LAES #CLOV #GGB #NVTS #ALIT #BHVN #BTBT #FUBO #RXRX #BITF #BBAI #DNN #SLDP #PLUG #USAR #OUST #ONDS #CRML - More: crystalequityresearch.com/most-searche... - #smallcap

FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia The troriluzole clinical development program encompassed the first industry clinical trials to generate data showing therapeutic potential in patients with spinocerebellar ataxia, a rare genetic, inherited, life-threatening neurodegenerative disease with no treatment options. Compelling data from troriluzole's new drug application included: a 3-...

#BHVN FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia

www.stocktitan.net/news/BHVN/fda-issues-com...

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! AM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

AM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #NKLR 56% OTM
2. #BHVN 36% OTM
3. #IREN 32% OTM
4. #SNDK 32% OTM
5. #BYND 30% OTM

#OptionFlow #OptionsTrading #Trading

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#NKLR, #BHVN, #SNDK, #BYND, #DDOG

#OptionFlow #OptionsTrading #Trading

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#FRMI, #ASPI, #BHVN, #CRSR, #CAN

#OptionFlow #OptionsTrading #Trading

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! PM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #IFRX 104% OTM
2. #BHVN 101% OTM
3. #AVXL 81% OTM
4. #CRCL 80% OTM
5. #BULL 73% OTM

#OptionFlow #OptionsTrading #Trading

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#IFRX, #BHVN, #CRCL, #BULL, #NKLR

#OptionFlow #OptionsTrading #Trading

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! PM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #BYND 48% OTM
2. #BHVN 42% OTM
3. #BMNR 37% OTM
4. #IONQ 37% OTM
5. #SANA 37% OTM

#OptionFlow #OptionsTrading #Trading

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#BHVN, #IONQ, #SANA, #SMR, #ANET

#OptionFlow #OptionsTrading #Trading

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! AM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

AM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #BHVN 42% OTM
2. #TSLA 37% OTM
3. #SANA 37% OTM
4. #TSM 34% OTM
5. #SMR 34% OTM

#OptionFlow #OptionsTrading #Trading

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#BHVN, #SANA, #SMR, #ANET, #APLD

#OptionFlow #OptionsTrading #Trading

#BHVN now 10P & 30C for Nov. Looks like a strangle that expects it either to dump under 5, or go to 35+ (to cover the entry cost as well).

News about this www.drugs.com/history/tror... is expected. Biotech gamble ⚠️!

#BHVN 20-40C spread for Jan. Trying to break out & chart looks very good. Biotech gamble ⚠️, but less so since it's not trial results.

Citi rated Biohaven as a Buy with a $28 price target, noting a de-risked valuation ahead of the Troriluzole FDA action.
www.drugs.com/history/tror...

Investors Alert: Biohaven Ltd. Faces Class Action Lawsuit Over Securities Fraud Allegations Biohaven Ltd. has been sued over securities violations, with investors urged to contact Levi & Korsinsky for guidance before the deadline.

Investors Alert: Biohaven Ltd. Faces Class Action Lawsuit Over Securities Fraud Allegations #United_States #New_York #Levi_&_Korsinsky #BHVN #Biohaven_Ltd.

The Gross Law Firm Files Securities Class Action for Biohaven Ltd. Shareholders The Gross Law Firm has initiated a securities class action targeting Biohaven Ltd. shareholders, urging those affected to join by September 12, 2025.

The Gross Law Firm Files Securities Class Action for Biohaven Ltd. Shareholders #United_States #New_York #Gross_Law_Firm #Biohaven_Ltd #BHVN

Class Action Lawsuit Filed Against Biohaven Ltd. and Key Executives Over Securities Violations Pomerantz Law Firm has initiated a class action lawsuit against Biohaven Ltd. and certain executives, alleging securities violations impacting investors who acquired shares between 2023 and 2025.

Class Action Lawsuit Filed Against Biohaven Ltd. and Key Executives Over Securities Violations #United_States #New_York #Pomerantz_Law #Biohaven_Ltd #BHVN

Investors in Biohaven Ltd. Can Lead Class Action Against Securities Fraud Investors who suffered losses with Biohaven Ltd. have a chance to take the lead in a securities fraud class action lawsuit against the company. Act before the deadline!

Investors in Biohaven Ltd. Can Lead Class Action Against Securities Fraud #United_States #Class_Action #Los_Angeles #Biohaven_Ltd #BHVN

Opportunity for Investors to Lead Securities Fraud Class Action Against Biohaven Ltd. (BHVN) Investors who suffered significant losses in Biohaven Ltd. may now file to lead a securities fraud class action lawsuit. Contact the law firm for more.

Opportunity for Investors to Lead Securities Fraud Class Action Against Biohaven Ltd. (BHVN) #USA #Securities_Fraud #Bensalem #Biohaven #BHVN

#BHVN
Random beaten down pharma name. Potential to squeeze on breakout. Also about to cross 55 EMA. Not sure about the strategy here. Double call spreads is a possibility. Calendar spread - short Oct, long Dec - also possible. 👀 for breakout, ignore otherwise.

Class Action Lawsuit Against Biohaven Ltd. Aims to Protect Investors' Rights A class action lawsuit has been filed against Biohaven Ltd., urging affected investors to join by September 12, 2025. Legal assistance is available.

Class Action Lawsuit Against Biohaven Ltd. Aims to Protect Investors' Rights #United_States #New_York #Levi_&_Korsinsky #BHVN #Biohaven_Ltd.